Dexcom Inc (NASDAQ: DXCM) is 11.25% higher on its value in year-to-date trading and has touched a low of $57.52 and a high of $132.26 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The DXCM stock was last observed hovering at around $84.11 in the last trading session, with the day’s gains setting it 2.41%.
Currently trading at $86.52, the stock is 14.17% and 19.73% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.83 million and changing 2.87% at the moment leaves the stock 15.05% off its SMA200. DXCM registered -31.90% loss for a year compared to 6-month loss of 23.67%.
The stock witnessed a 28.39% gain in the last 1 month and extending the period to 3 months gives it a 3.16%, and is 3.80% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.64% over the week and 3.53% over the month.
Dexcom Inc (DXCM) has around 10300 employees, a market worth around $33.93B and $4.15B in sales. Current P/E ratio is 64.95 and Fwd P/E is 33.99. Profit margin for the company is 12.90%. Distance from 52-week low is 50.42% and -34.58% from its 52-week high. The company has generated returns on investments over the last 12 months (14.78%).
The EPS is expected to grow by 23.45% this year
The shares outstanding are 392.10M, and float is at 386.62M with Short Float at 2.95%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 46.51 million shares valued at $5.27 billion. The investor’s holdings represent 11.6516 of the DXCM Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 34.52 million shares valued at $3.91 billion to account for 8.6471 of the shares outstanding. The other top investors are STATE STREET CORP which holds 16.31 million shares representing 4.0853 and valued at over $1.85 billion, while BAILLIE GIFFORD & CO holds 3.8392 of the shares totaling 15.33 million with a market value of $1.74 billion.
Dexcom Inc (DXCM) Insider Activity
The most recent transaction is an insider sale by Heller Bridgette P, the company’s Director. SEC filings show that Heller Bridgette P sold 352 shares of the company’s common stock on Mar 17 ’25 at a price of $70.33 per share for a total of $24756.0. Following the sale, the insider now owns 22997.0 shares.
Still, SEC filings show that on Mar 12 ’25, Leach Jacob Steven (EVP, Chief Operating Officer) disposed off 14,076 shares at an average price of $70.38 for $0.99 million. The insider now directly holds 313,497 shares of Dexcom Inc (DXCM).
